Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life.
Alopecia
Baldness
Hair loss
Hair regrowth
PRP
Platelet-rich plasma
Journal
Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
01
11
2022
accepted:
03
12
2022
medline:
23
10
2023
pubmed:
14
1
2023
entrez:
13
1
2023
Statut:
ppublish
Résumé
While numerous studies have demonstrated enhanced hair growth following platelet-rich plasma (PRP) treatments in patients with male and female pattern hair loss, no study has demonstrated its impact on quality of life (QoL) using a validated tool. This prospective study aimed to assess the psychological impact of PRP treatment for hair loss. PRP scalp injections were repeated monthly for the first 3 months, then quarterly for 1 year, and annually thereafter. HAIRDEX 48, a validated scale assessing QoL for patients with alopecia, was administered before PRP and at each visit. Scores were interpolated on a 0-100 scale: 0 representing highest QoL, 100 lowest, and compared using paired t-tests. Ninety-two patients receiving PRP were analyzed. Mean age was 48.2 ± 17.4 years and 55% were male. Patients had an average of 4 ± 2 treatments; most (60%) had ≥4. Thirty patients (33%) completed both pre- and post-PRP questionnaires. Prior to PRP, 61% tried minoxidil, 16% finasteride, and 1% hair transplant. Total HAIRDEX scores improved from a mean of 23.2 ± 15.4 to 19.7 ± 11.3 after 3-5 months after PRP (p < 0.001). There were also decreases in symptoms (10.0 ± 12.0 vs. 9.6 ± 10.8, p < 0.001), functioning (16.1 ± 18.1 vs. 13.3 ± 12.6, p < 0.001), and emotions domains (37.7 ± 24.1 vs. 32.2 ± 18.9, p < 0001). For stigmatization and self-confidence domains, improvements from pre-PRP were significant at 3-5 months (21.2 ± 16.8 vs. 17.4 ± 12.1; p < 0.001 and 24.8 ± 17.7 vs. 20.9 ± 15.5; p < 0.001, respectively) and >6 months (18.9 ± 13.9; p < 0.001 and19.5 ± 18.6; p = 0.008, respectively). PRP improves QoL and is an effective part of multimodal therapy for hair loss. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Sections du résumé
BACKGROUND
While numerous studies have demonstrated enhanced hair growth following platelet-rich plasma (PRP) treatments in patients with male and female pattern hair loss, no study has demonstrated its impact on quality of life (QoL) using a validated tool.
OBJECTIVE
This prospective study aimed to assess the psychological impact of PRP treatment for hair loss.
METHODS
PRP scalp injections were repeated monthly for the first 3 months, then quarterly for 1 year, and annually thereafter. HAIRDEX 48, a validated scale assessing QoL for patients with alopecia, was administered before PRP and at each visit. Scores were interpolated on a 0-100 scale: 0 representing highest QoL, 100 lowest, and compared using paired t-tests.
RESULTS
Ninety-two patients receiving PRP were analyzed. Mean age was 48.2 ± 17.4 years and 55% were male. Patients had an average of 4 ± 2 treatments; most (60%) had ≥4. Thirty patients (33%) completed both pre- and post-PRP questionnaires. Prior to PRP, 61% tried minoxidil, 16% finasteride, and 1% hair transplant. Total HAIRDEX scores improved from a mean of 23.2 ± 15.4 to 19.7 ± 11.3 after 3-5 months after PRP (p < 0.001). There were also decreases in symptoms (10.0 ± 12.0 vs. 9.6 ± 10.8, p < 0.001), functioning (16.1 ± 18.1 vs. 13.3 ± 12.6, p < 0.001), and emotions domains (37.7 ± 24.1 vs. 32.2 ± 18.9, p < 0001). For stigmatization and self-confidence domains, improvements from pre-PRP were significant at 3-5 months (21.2 ± 16.8 vs. 17.4 ± 12.1; p < 0.001 and 24.8 ± 17.7 vs. 20.9 ± 15.5; p < 0.001, respectively) and >6 months (18.9 ± 13.9; p < 0.001 and19.5 ± 18.6; p = 0.008, respectively).
CONCLUSIONS
PRP improves QoL and is an effective part of multimodal therapy for hair loss.
LEVEL OF EVIDENCE IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Identifiants
pubmed: 36637490
doi: 10.1007/s00266-022-03224-8
pii: 10.1007/s00266-022-03224-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1528-1534Informations de copyright
© 2023. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.
Références
Nyholt DR, Gillespie NA, Heath AC, Martin NG (2003) Genetic basis of male pattern baldness. J Invest Dermatol 121:1561–1564. https://doi.org/10.1111/J.1523-1747.2003.12615.X
doi: 10.1111/J.1523-1747.2003.12615.X
pubmed: 14675213
Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68:1359–1365. https://doi.org/10.1097/00007611-197511000-00009
doi: 10.1097/00007611-197511000-00009
pubmed: 1188424
Liu F, Hamer MA, Heilmann S et al (2016) Prediction of male-pattern baldness from genotypes. Eur J Hum Genet 24:895–902. https://doi.org/10.1038/ejhg.2015.220
doi: 10.1038/ejhg.2015.220
pubmed: 26508577
Uebel CO, da Silva JB, Cantarelli D, Martins P (2006) The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 118:1458–1466. https://doi.org/10.1097/01.PRS.0000239560.29172.33
doi: 10.1097/01.PRS.0000239560.29172.33
pubmed: 17051119
Meyers AE, Jin A, Kwiecien GJ, Zins JE (2021) Basic science of PRP. In: Khetarpal S (ed) Aesthetic clinician’s guide to platelet rich plasma. Springer, Cham, pp 9–23
doi: 10.1007/978-3-030-81427-4_2
Khaled Yaseer S, Jamil Hassan F, Badi Suleiman H (2020) Efficacy of platelet rich plasma intradermal injections for androgenetic alopecia treatment in males: a before and after study. Actas Dermosifiliogr. https://doi.org/10.1016/j.ad.2019.11.004
doi: 10.1016/j.ad.2019.11.004
pubmed: 32401718
Gentile RD (2020) Easy platelet-rich fibrin (injectable/topical) for post-resurfacing and microneedle therapy. Facial Plast Surg Clin North Am 28:127–134. https://doi.org/10.1016/j.fsc.2019.09.011
doi: 10.1016/j.fsc.2019.09.011
pubmed: 31779936
Semsarzadeh N, Khetarpal S (2020) Platelet-rich plasma and stem cells for hair growth: a review of the literature. Aesthet Surg J / Am Soc Aesthet Plast Surg 40:NP177–NP188. https://doi.org/10.1093/asj/sjz146
Keene SA, Ceh V, Sideris K (2020) ISHRS practice census offers key insights on hair restoration practices and procedures. Hair Transpl Forum Int 30:97–97. https://doi.org/10.3358/30.3.97
doi: 10.3358/30.3.97
ASPS recommends the use of plastic surgery specific patient-reported outcome measures | ASPS. https://www.plasticsurgery.org/news/press-releases/asps-recommends-the-use-of-plastic-surgery-specific-patient-reported-outcome-measures . Accessed 6 Jul 2022
Sharma K, Steele K, Birks M et al (2019) Patient-reported outcome measures in plastic surgery: an introduction and review of clinical applications. Ann Plast Surg 83:247–252. https://doi.org/10.1097/SAP.0000000000001894
doi: 10.1097/SAP.0000000000001894
pubmed: 31415290
Gummesson C, Ward MM, Atroshi I (2006) The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord. https://doi.org/10.1186/1471-2474-7-44
doi: 10.1186/1471-2474-7-44
pubmed: 16709254
pmcid: 1513569
Gummesson C, Atroshi I, Ekdahl C (2003) The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord 4:1–6. https://doi.org/10.1186/1471-2474-4-11
doi: 10.1186/1471-2474-4-11
Klassen AF, Cano SJ, Schwitzer JA et al (2016) Development and psychometric validation of the FACE-Q Skin, lips, and facial rhytids appearance scales and adverse effects checklists for cosmetic procedures. JAMA Dermatol 152:443–451. https://doi.org/10.1001/JAMADERMATOL.2016.0018
doi: 10.1001/JAMADERMATOL.2016.0018
pubmed: 26934294
pmcid: 4833666
Pusic AL, Klassen AF, Scott AM et al (2009) Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg 124:345–353. https://doi.org/10.1097/PRS.0B013E3181AEE807
doi: 10.1097/PRS.0B013E3181AEE807
pubmed: 19644246
Klassen AF, Cano SJ, Scott AM, Pusic AL (2014) Measuring outcomes that matter to face-lift patients: development and validation of FACE-Q appearance appraisal scales and adverse effects checklist for the lower face and neck. Plast Reconstr Surg 133:21–30. https://doi.org/10.1097/01.PRS.0000436814.11462.94
doi: 10.1097/01.PRS.0000436814.11462.94
pubmed: 24105086
Wu SS, Duraes EFR, Scomacao I et al (2022) Beauty is in the eye of the beholder: factors influencing disparity in perceptions of breast reconstruction aesthetic outcomes. Plast Reconstr Surg 150:42E-50E. https://doi.org/10.1097/PRS.0000000000009254
doi: 10.1097/PRS.0000000000009254
pubmed: 35499515
Duraes EFR, Durand P, Morisada M et al (2022) A novel validated breast aesthetic scale. Plast Reconstr Surg 149:1297–1308. https://doi.org/10.1097/PRS.0000000000009156
doi: 10.1097/PRS.0000000000009156
pubmed: 35349538
Chren MM, Lasek RJ, Quinn LM et al (1996) Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 107:707–713. https://doi.org/10.1111/1523-1747.EP12365600
doi: 10.1111/1523-1747.EP12365600
pubmed: 8875954
Mostaghimi A, Napatalung L, Sikirica V et al (2021) Patient perspectives of the social, emotional and functional impact of Alopecia areata: a systematic literature review. Dermatol Ther (Heidelb) 11:867–883. https://doi.org/10.1007/s13555-021-00512-0
doi: 10.1007/s13555-021-00512-0
pubmed: 33770385
Freites-Martinez A, Chan D, Sibaud V et al (2019) Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy Alopecia. JAMA Dermatol 155:724–728. https://doi.org/10.1001/JAMADERMATOL.2018.5071
doi: 10.1001/JAMADERMATOL.2018.5071
pubmed: 30840033
pmcid: 6563563
Rosati P, Barone M, Alessandri Bonetti M et al (2019) A systematic review of outcomes and patient satisfaction following surgical and non-surgical treatments for hair loss. Aesthet Plast Surg 43:1523–1535. https://doi.org/10.1007/S00266-019-01480-9
doi: 10.1007/S00266-019-01480-9
Liu Y, Liu F, Qu Q et al (2019) Evaluating the satisfaction of patients undergoing hair transplantation surgery using the FACE-Q scales. Aesthet Plast Surg 43:376–382. https://doi.org/10.1007/S00266-018-1292-X
doi: 10.1007/S00266-018-1292-X
Puig CJ, Reese R, Peters M (2016) Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic Alopecia. Dermatol Surg 42:1243–1247. https://doi.org/10.1097/DSS.0000000000000883
doi: 10.1097/DSS.0000000000000883
pubmed: 27608205
Tawfik AA, Osman MAR (2018) The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study. J Cosmet Dermatol 17:47–53. https://doi.org/10.1111/JOCD.12357
doi: 10.1111/JOCD.12357
pubmed: 28503741
Gkini M-A, Kouskoukis A-E, Tripsianis G et al (2014) Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 7:213–219. https://doi.org/10.4103/0974-2077.150743
doi: 10.4103/0974-2077.150743
pubmed: 25722600
pmcid: 4338465
Motosko CC, Khouri KS, Poudrier G et al (2018) Evaluating platelet-rich therapy for facial aesthetics and Alopecia: a critical review of the literature. Plast Reconstr Surg 141:1115–1123. https://doi.org/10.1097/PRS.0000000000004279
doi: 10.1097/PRS.0000000000004279
pubmed: 29697605